26
Mar

After collaborating with the University of Michigan-spinout NanoBio over the past three years, Merck has signed off on a new licensing pact for the biotech’s nanoemulsion adjuvant technology.

…read more

Source: Merck snags rights to NanoBio’s adjuvant vaccine tech

    

0 No comments